A detailed history of New Edge Advisors, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, New Edge Advisors, LLC holds 13,369 shares of CDXC stock, worth $73,395. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,369
Holding current value
$73,395
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.51 - $3.8 $33,556 - $50,802
13,369 New
13,369 $48,000
Q1 2024

May 14, 2024

BUY
$1.36 - $3.84 $29,124 - $82,233
21,415 New
21,415 $74,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $375M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.